Bovine Lactoferrin Decreases Cholera-Toxin-Induced Intestinal Fluid Accumulation in Mice by Ganglioside Interaction

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Rivera, Fulton P ^a,b   Medina, Anicia M ^a   Bezada, Sandra ^c   Valencia, Roberto ^d   Bernal, María ^e   Meza, Rina ^e   Maves, Ryan C ^e,f   Ochoa, Theresa J ^a,g  

^a INSTITUTO DE MEDICINA TROPICAL ALEXANDER VON HUMBOLDT   (Peru)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c UNIVERSIDAD NACIONAL MAYOR DE SAN MARCOS   (Peru)

^d UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^e Peru   (Peru)

^f NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^g UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE LACTOFERRIN; CHOLERA TOXIN; ESCHERICHIA COLI ENTEROTOXIN; GANGLIOSIDE GM1; GANGLIOSIDE GM1 RECEPTOR; LACTOFERRIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENTEROPATHY; ENTEROTOXIGENIC ESCHERICHIA COLI; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; ILEUM; INTESTINAL FLUID ACCUMULATION; INTESTINE FLUID; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; PROTEIN SUBUNIT;

ANIMALS; CATTLE; CHLORIDES; CHOLERA TOXIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENTEROTOXINS; ESCHERICHIA COLI; FEMALE; FERRIC COMPOUNDS; G(M1) GANGLIOSIDE; GANGLIOSIDES; INTESTINES; LACTOFERRIN; MICE; PROTEIN BINDING; RECEPTORS, CELL SURFACE;

BOVINAE; MUS;

EID: 84875990993     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059253     Document Type: Article

References (35)

1. Merritt EA, Hol WG, (1995) AB5 toxins. Curr Opin Struct Biol 5: 165-171.
2. Jones G, Steketee RW, Black RE, Bhutta ZA, Morris SS, et al. (2003) How many child deaths can we prevent this year? Lancet 362: 65-71.
3. Brines RD, Brock JH, (1983) The effect of trypsin and chymotrypsin on the in vitro antimicrobial and iron-binding properties of lactoferrin in human milk and bovine colostrum. Unusual resistance of human apolactoferrin to proteolytic digestion. Biochim Biophys Acta 759: 229-235.
4. Drescher K, Roos N, Pfeuffer M, Seyfert HM, Schrezenmeir J, et al. (1999) Recovery of 15N-lactoferrin is higher than that of 15N-casein in the small intestine of suckling, but not adult miniature pigs. J Nutr 129: 1026-1030.
5. Troost FJ, Steijns J, Saris WH, Brummer RJ, (2001) Gastric digestion of bovine lactoferrin in vivo in adults. J Nutr 131: 2101-2104.
6. Morrow AL, Rangel JM, (2004) Human milk protection against infectious diarrhea: implications for prevention and clinical care. Semin Pediatr Infect Dis 15: 221-228.
7. Ochoa TJ, Cleary TG, (2009) Effect of lactoferrin on enteric pathogens. Biochimie 91: 30-34.
8. Samson RR, Mirtle C, McClelland DB, (1980) The effect of digestive enzymes on the binding and bacteriostatic properties of lactoferrin and vitamin B12 binder in human milk. Acta Paediatr Scand 69: 517-523.
9. Brock JH, Pickering MG, McDowall MC, Deacon AG, (1983) Role of antibody and enterobactin in controlling growth of Escherichia coli in human milk and acquisition of lactoferrin- and transferrin-bound iron by Escherichia coli. Infect Immun 40: 453-459.
10. Visca P, Dalmastri C, Verzili D, Antonini G, Chiancone E, et al. (1990) Interaction of lactoferrin with Escherichia coli cells and correlation with antibacterial activity. Med Microbiol Immunol 179: 323-333.
11. Yamauchi K, Tomita M, Giehl TJ, Ellison RT 3rd, (1993) Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment. Infect Immun 61: 719-728.
12. Appelmelk BJ, An YQ, Geerts M, Thijs BG, de Boer HA, et al. (1994) Lactoferrin is a lipid A-binding protein. Infect Immun 62: 2628-2632.
13. Valenti P, Antonini G, (2005) Lactoferrin: an important host defence against microbial and viral attack. Cell Mol Life Sci 62: 2576-2587.
14. Spangler BD, (1992) Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. Microbiol Rev 56: 622-647.
15. Pickens JC, Merritt EA, Ahn M, Verlinde CL, Hol WG, et al. (2002) Anchor-based design of improved cholera toxin and E. coli heat-labile enterotoxin receptor binding antagonists that display multiple binding modes. Chem Biol 9: 215-224.
16. Mitchell DD, Pickens JC, Korotkov K, Fan E, Hol WG, (2004) 3,5-Substituted phenyl galactosides as leads in designing effective cholera toxin antagonists; synthesis and crystallographic studies. Bioorg Med Chem 12: 907-920.
17. Garg P, Chakraborty S, Basu I, Datta S, Rajendran K, et al. (2000) Expanding multiple antibiotic resistance among clinical strains of Vibrio cholerae isolated from 1992-7 in Calcutta, India. Epidemiol Infect 124: 393-399.
18. Field M, (2003) Intestinal ion transport and the pathophysiology of diarrhea. J Clin Invest 111: 931-943.
19. Kawasaki Y, Isoda H, Tanimoto M, Dosako S, Idota T, et al. (1992) Inhibition by lactoferrin and kappa-casein glycomacropeptide of binding of Cholera toxin to its receptor. Biosci Biotechnol Biochem 56: 195-198.
20. Farnaud S, Evans RW, (2003) Lactoferrin-a multifunctional protein with antimicrobial properties. Mol Immunol 40: 395-405.
21. Dionysius DA, Grieve PA, Milne JM, (1993) Forms of lactoferrin: their antibacterial effect on enterotoxigenic Escherichia coli. J Dairy Sci 76: 2597-2600.
22. De Oliveira IR, de Araújo AN, Bao SN, Giugliano LG, (2001) Binding of lactoferrin and free secretory component to enterotoxigenic Escherichia coli. FEMS Microbiol Lett 203: 29-33.
23. Giugliano LG, Ribeiro ST, Vainstein MH, Ulhoa CJ, (1995) Free secretory component and lactoferrin of human milk inhibit the adhesion of enterotoxigenic Escherichia coli. J Med Microbiol 42: 3-9.
24. De Oliveira IR, Bessler HC, Bao SN, Lima R, Giugliano LG, (2007) Inhibition of enterotoxigenic Escherichia coli (ETEC) adhesion to caco-2 cells by human milk and its inmunoglobulin and non-inmunoglobulin fractions. Brazilian Journal of Microbiology 38: 86-92.
25. Kawasaki Y, Tazume S, Shimizu K, Matsuzawa H, Dosako S, et al. (2000) Inhibitory effects of bovine lactoferrin on the adherence of enterotoxigenic Escherichia coli to host cells. Biosci Biotechnol Biochem 64: 348-354.
26. Ochoa TJ, Peso A, Cruz K, Chea-Woo E, Cleary TG, (2012) Clinical studies of lactoferrin in children. Biochem Cell Biol 90: 457-467.
27. Zavaleta N, Figueroa D, Rivera J, Sánchez J, Alfaro S, et al. (2007) Efficacy of rice-based oral rehydration solution containing recombinant human lactoferrin and lysozyme in Peruvian children with acute diarrhea. J Pediatr Gastroenterol Nutr 44: 258-264.
28. Svennerholm AM, Steele D, (2004) Microbial-gut interactions in health and disease. Progress in enteric vaccine development. Best Pract Res Clin Gastroenterol 18: 421-445.
29. Sack DA, Sack RB, Nair GB, Siddique AK, (2004) Cholera. Lancet 363: 223-233.
30. Farmer P, Almazor CP, Bahnsen ET, Barry D, Bazile J, et al. (2011) Meeting cholera's challenge to Haiti and the world: a joint statement on cholera prevention and care. PLoS Negl Trop Dis 5: e1145.
31. Qadri F, Svennerholm AM, Faruque AS, Sack RB, (2005) Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention. Clin Microbiol Rev 18: 465-483.
32. Sánchez J, Holmgren J, (2005) Virulence factors, pathogenesis and vaccine protection in cholera and ETEC diarrhea. Curr Opin Immunol 17: 388-398.
33. Ajello M, Greco R, Giansanti F, Massucci MT, Antonini G, et al. (2002) Anti-invasive activity of bovine lactoferrin towards group A streptococci. Biochem Cell Biol 80: 119-124.
34. Svennerholm AM, Wiklund G, (1983) Rapid GM1-enzyme-linked immunosorbent assay with visual reading for identification of Escherichia coli heat-labile enterotoxin. J Clin Microbiol 17: 596-600.
35. Chen JC, Huang LJ, Wu SL, Kuo SC, Ho TY, et al. (2007) Hsiang CY. Ginger and its bioactive component inhibit enterotoxigenic Escherichia coli heat-labile enterotoxin-induced diarrhea in mice. J Agric Food Chem 55: 8390-8397.